Biotech and pharmaceutical investors, among others, need to watch out for the way firms treat the cost of developing new products, as this can have a big impact on a firm’s results. In his fifth video in the ‘cooking the books’ series, Tim Bennett explains how.
Articles written by Tim Bennett
As investors, we are our own worst enemies. We all think we are cleverer than we really are, and let our emotions get the better of us. Usually, we lose money, says Tim Bennett. Here’s how to avoid that.
One of the stock market’s more reliable valuation tools is suggesting stocks are a buy. But beware – while it may have worked in the past, relying on it now looks risky.
Pick up two sets of accounts for similar firms and you may find radically different numbers. Tim Bennett explains why this happens, and what you can do about it.
Hunting for quality stocks in a troubled market can be fraught with danger. Here, Tim Bennett explains the fives tests that alert you to when a share is a bargain buy.
In the third of his ‘cooking the books’ series of videos, Tim Bennett explains how investors can be fooled by the treatment of long-term assets, and offers a couple of solutions.
There are many crafty tricks that smart directors can employ to flatter their reported profits, says Tim Bennett. Here, he describes three of the most common, and how you can spot them.
Tim Bennett rounds up this week’s personal finance news, including the reality behind the rising housing-market figures, and how to avoid getting fleeced on rental car charges.
Tim Bennett takes a look at how companies can manipulate what accountants call ‘provisions’ to create the profit profile they want investors to see. He also explains how you can avoid being fooled.
There are lots of ways directors can make it look as though their company is more profitable than it is. Tim Bennett looks at one, and explains what you should look out for.